An FDA-cleared digital treatment for insomnia patients

SleepioRx is a digital treatment that teaches patients techniques rooted in cognitive-behavioral therapy (CBT), the first-line recommended treatment for insomnia.

Get Started

In a clinical trial, 76% of SleepioRx patients experienced clinically significant improvements in insomnia

54%

reduction in time to fall asleep.1

62%

less time awake at night.1

45%

better functioning the next day.1

For the past decade, we’ve been putting SleepioRx to the test in gold-standard clinical trials.

22 clinical trials replicating effectiveness in improving insomnia and sleep outcomes
‍
‍Peer-reviewed publications in JAMA Psychiatry, The Lancet, and SLEEP
‍
Referenced in 4 US and international clinical guidelines, including NICE2

An effective tool for supporting your practice

SleepioRx enhances provider care plans by making CBT-I accessible on-demand. In 5 minutes or less, patients can learn techniques to help them quiet their racing minds, reshape behaviors, and resolve sleep troubles — available to them 24/7.

Immediate access to first-line care

When it’s needed the most, SleepioRx is instantly accessible and ready to check in, practice, or try a new technique. No waitlists required.

Non-drug option that patients prefer

SleepioRx targets the root cause of insomnia to deliver lasting results for the 75% of patients who say they’d prefer a non-drug option.3

Seamless, low-lift implementation

We make it easy for you to unlock access to care for patients through a simple and streamlined implementation process.

What SleepioRx patients say

“I’ve struggled with insomnia for years and poor sleep was starting to negatively impact my day-to-day life. Sleepio gave me the tools I needed to establish a sleep schedule and maintain good sleep hygiene.”

"This program is very authentic. It’s science-based about the biology of sleep, and there is data to back it up. "

“I wish I had known about CBT and SleepioRx sooner. It is very interactive, to the point, and gets the important information across in a very understandable way. It has definitely improved my sleep.”

Ready to learn more?

Get started

Related reading

Managing Anxiety Under Pressure at Work

Report
Bridging the gap: Mental health equity in the digital age

How digital care can help close the care gap in marginalized communities.

Blog /
5
 min read
The hidden costs of neglecting mental health in the workplace

Discover the hidden impact of mental health and get strategies for a healthier, more productive workforce.

Blog /
4
 min read

1. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.
2. Miller, C. B., Carl, J. R., Henry, A. L., Baker, L. (2020). A health economic evaluation of Sleepio at a Fortune 500 company. Retrieved from: https://go.bighealth.com/report/health-economic-evaluation. *This is a total estimate that is based on statistically significant and non-significant reductions in costs across categories; thus the exact figure would require confirmation in further research with a larger sample size.

SleepioRx is a digital therapeutic intended for the treatment of chronic insomnia/insomnia disorder as an adjunct to usual care in patients aged 18 and older. Sleepio is a prescription device delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) and can be made available on the order of a licensed healthcare provider. Patients should read the indications for use.

DOC-3652 Effective Aug 2024